Nasdaq: Completed Antitrust Review for Adenza Buy, Sees Closing in 4Q
Nasdaq: Completed Antitrust Review for Adenza Buy, Sees Closing in 4Q。
Nasdaq: Completed Antitrust Review for Adenza Buy, Sees Closing in 4Q Read Post »
Nasdaq: Completed Antitrust Review for Adenza Buy, Sees Closing in 4Q。
Nasdaq: Completed Antitrust Review for Adenza Buy, Sees Closing in 4Q Read Post »
Nasdaq: Fully Prepared to Execute Capital Plan to Pay Down Debt, Increase Dividend, Buy Back Shares in Coming Quarters。
Nasdaq Q3 Solutions Businesses Revenues $694M, Up 9%; Trading Services Net Revenues $236M, Down 1%。
NASDAQ Posts Q3 EPS $0.71, vs. Street Est of $0.68。
NASDAQ Posts Q3 EPS $0.71, vs. Street Est of $0.68 Read Post »
Procter & Gamble (NYSE:PG) Announces Fiscal Year 2024 First Quarter Results Net Sales +6%; Organic Sales +7% Diluted EPS and Core EPS $1.83, each +17% UPDATES ALL-IN SALES GROWTH OUTLOOK October 18, 2023– The Procter & Gamble Company (NYSE:PG) reported first quarter fiscal year 2024 net sales of $21.9 billion, an increase of six percent versus the prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased seven percent. Diluted net earnings per share were $1.83, an increase of 17% versus prior year. Operating cash flow was $4.9 billion, and net earnings were $4.6 billion for the quarter. Adjusted free cash flow productivity was 97%, which is calculated as operating cash flow excluding capital spending and certain other items, as a percentage of net earnings. The Company returned $3.8 billion of cash to shareowners via approximately $2.3 billion of dividend payments and $1.5 billion
Procter & Gamble (NYSE:PG) Announces Fiscal Year 2024 First Quarter Results Read Post »
Procter & Gamble (NYSE:PG) Still Sees FY24 EPS Growth in Range of Up 6%-9% Vs. FY23 EPS $5.90。
Procter & Gamble (NYSE:PG) Q1 Sales $21.9 Bln, up 6%; FactSet Consensus $21.6 Bln。
Procter & Gamble (NYSE:PG) Q1 Sales $21.9 Bln, up 6%; FactSet Consensus $21.6 Bln Read Post »
ASML (ASML.AS) said Wednesday that net income and sales gained year over year in the third quarter of 2023. Net income for the three months ended Oct. 1 was 1.89 billion euros, compared with 1.70 billion euros a year ago. EPS was 4.81 euros, compared with 4.29 euros. Net sales of the chip-making equipment maker were 6.67 billion euros, compared with 5.78 billion euros previously. Analysts polled by Visible Alpha were expecting 1.80 billion euros in net income or 4.57 euros per share, while revenue was estimated at 6.69 billion euros. Meanwhile, the board announced an interim dividend of 1.45 euros per share for the period, payable on Nov. 10 to shareholders on record Nov. 2. It paid 1.37 euros per share a year ago. Looking ahead, the Dutch company expects net sales between 6.7 billion euros and 7.1 billion euros for the fourth quarter. It also restated its expectation
ASML Posts Growth in Q3 Net Income, Sales Read Post »
By Tae Kim Investors are expecting Netflix to give updates about the progress of its ad subscription plan and pricing strategy after the market close. Some analysts are worried changes on either front could dampen future growth. For the third quarter, the consensus for Netflix (ticker: NFLX) is for the company to report revenue of $8.54 billion with earnings per share of $3.49 and 6.1 million in paid net add subscriptions. Analysts’ estimates for the current quarter are EPS of $2.17, net adds of 7.7 million, and $8.78 billion in revenue. Last week, Wolfe analyst Peter Supino lowered his rating to Peer Perform from Outperform for Netflix and removed his $500 price target on the stock, citing worries about growth in the coming years.
Netflix Reports Earnings Today. Growth Is at Risk. — Barrons.com Read Post »
ASML Holding (NASDAQ:ASML) reported quarterly earnings of $5.24 per share which beat the analyst consensus estimate of $5.00 by 4.7 percent. This is a 21.18 percent increase over earnings of $4.32 per share from the same period last year. The company reported quarterly sales of $7.26 billion which missed the analyst consensus estimate of $7.49 billion by 3.04 percent. This is a 24.64 percent increase over sales of $5.83 billion the same period last year.
ASML Holding Q3 EPS $5.24 Beats $5.00 Estimate, Sales $7.26B Miss $7.49B Estimate Read Post »
Johnson & Johnson (NYSE: JNJ) Exec Says Co Expects To File For Regulatory Approval For Lung Cancer Therapy In 2025.
Wells Fargo analyst Elyse Greenspan maintains American Intl Gr (NYSE:AIG) with a Equal-Weight and raises the price target from $62 to $64.
Wells Fargo raises American Intl Gr (NYSE:AIG) price target from $62 to $64 Read Post »